SE7708521L - PROCEDURE FOR THE PREPARATION OF AMINOAL CYLFURAN DERIVATIVES WITH THERAPEUTIC EFFECT - Google Patents

PROCEDURE FOR THE PREPARATION OF AMINOAL CYLFURAN DERIVATIVES WITH THERAPEUTIC EFFECT

Info

Publication number
SE7708521L
SE7708521L SE7708521A SE7708521A SE7708521L SE 7708521 L SE7708521 L SE 7708521L SE 7708521 A SE7708521 A SE 7708521A SE 7708521 A SE7708521 A SE 7708521A SE 7708521 L SE7708521 L SE 7708521L
Authority
SE
Sweden
Prior art keywords
cylfuran
aminoal
derivatives
procedure
preparation
Prior art date
Application number
SE7708521A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE437373B (en
Inventor
B J Price
J W Clitherow
J Bradshaw
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27448487&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE7708521(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB32465/76A external-priority patent/GB1565966A/en
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Priority claimed from KR7701808A external-priority patent/KR810000355B1/en
Publication of SE7708521L publication Critical patent/SE7708521L/en
Publication of SE437373B publication Critical patent/SE437373B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE7708521A 1976-08-04 1977-07-25 PROCEDURE FOR PREPARING AN AMINOAL COOLING RANGE DERIVATIVE WITH THERAPEUTIC EFFECT SE437373B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB32465/76A GB1565966A (en) 1976-08-04 1976-08-04 Aminoalkyl furan derivatives
GB5068576 1976-12-06
GB2018777 1977-05-13
KR7701808A KR810000355B1 (en) 1977-05-13 1977-08-04 Preparation for pharmacologically active compounds

Publications (2)

Publication Number Publication Date
SE7708521L true SE7708521L (en) 1978-02-05
SE437373B SE437373B (en) 1985-02-25

Family

ID=27448487

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7708521A SE437373B (en) 1976-08-04 1977-07-25 PROCEDURE FOR PREPARING AN AMINOAL COOLING RANGE DERIVATIVE WITH THERAPEUTIC EFFECT
SE8205533A SE454882B (en) 1976-08-04 1982-09-28 PROCEDURE FOR THE PREPARATION OF AMINOAL COOLING RANGE DERIVATIVES WITH THERAPEUTIC EFFECT
SE8206556A SE454883B (en) 1976-08-04 1982-11-17 AMINOALKYL REFERENCE DERIVATIVES FOR USING INTERMEDIATES IN THE PREPARATION OF AMINOALKYL REFERENCE DERIVATIVES WITH THERAPEUTIC EFFECT

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE8205533A SE454882B (en) 1976-08-04 1982-09-28 PROCEDURE FOR THE PREPARATION OF AMINOAL COOLING RANGE DERIVATIVES WITH THERAPEUTIC EFFECT
SE8206556A SE454883B (en) 1976-08-04 1982-11-17 AMINOALKYL REFERENCE DERIVATIVES FOR USING INTERMEDIATES IN THE PREPARATION OF AMINOALKYL REFERENCE DERIVATIVES WITH THERAPEUTIC EFFECT

Country Status (16)

Country Link
AT (1) AT375931B (en)
CH (2) CH642072A5 (en)
CY (1) CY1077A (en)
DE (2) DE2760097C2 (en)
DK (2) DK148258C (en)
ES (2) ES461334A1 (en)
FI (1) FI72318C (en)
HK (1) HK55780A (en)
IE (1) IE45456B1 (en)
IT (2) IT1126759B (en)
KE (1) KE3080A (en)
NZ (2) NZ191383A (en)
PH (1) PH13540A (en)
PT (1) PT66874B (en)
SE (3) SE437373B (en)
YU (2) YU40006B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203909A (en) * 1978-09-26 1980-05-20 Bristol-Myers Company Furan compounds
YU52598A (en) * 1998-11-19 2001-05-28 D.D. Zdravlje- sektor za istraživanje i razvoj Procedure for synthesis of n-[2[[[5-[ (dialkylamino)methyl] -2-furanil]methyl]thi0]etyl]-n'-alkyl-2-nitro 1,1 alkendiamine and its hydrochloride

Also Published As

Publication number Publication date
DK416384D0 (en) 1984-08-30
SE437373B (en) 1985-02-25
SE454883B (en) 1988-06-06
DK337977A (en) 1978-02-05
NZ184759A (en) 1980-09-12
IE45456L (en) 1978-02-04
SE8205533D0 (en) 1982-09-28
DK149952C (en) 1987-07-06
PT66874A (en) 1977-09-01
HK55780A (en) 1980-10-10
YU200082A (en) 1983-01-21
FI772264A (en) 1978-02-05
DK149952B (en) 1986-11-03
FI72318C (en) 1987-05-11
CY1077A (en) 1980-12-27
IT1126759B (en) 1986-05-21
IT8548437A0 (en) 1985-08-01
DE2760097C2 (en) 1989-08-17
ES470836A1 (en) 1979-02-16
NZ191383A (en) 1980-09-12
DE2759959C2 (en) 1988-08-04
DK416384A (en) 1984-08-30
SE8206556L (en) 1982-11-17
YU40088B (en) 1985-06-30
SE454882B (en) 1988-06-06
SE8205533L (en) 1982-09-28
YU191177A (en) 1983-01-21
YU40006B (en) 1985-06-30
IT1221058B (en) 1990-06-21
DK148258C (en) 1985-10-14
CH641176A5 (en) 1984-02-15
FI72318B (en) 1987-01-30
PH13540A (en) 1980-06-26
SE8206556D0 (en) 1982-11-17
CH642072A5 (en) 1984-03-30
ATA574077A (en) 1984-02-15
KE3080A (en) 1980-10-03
DK148258B (en) 1985-05-20
ES461334A1 (en) 1979-05-16
IE45456B1 (en) 1982-08-25
PT66874B (en) 1979-01-23
AT375931B (en) 1984-09-25

Similar Documents

Publication Publication Date Title
SE434395B (en) ANALOGY PROCEDURE FOR PREPARING CARBOSTYRIC DERIVATIVES WITH THERAPEUTIC EFFECT
SE7805590L (en) PROCEDURE FOR THE PREPARATION OF AMINOAL COLD DERIVATIVES WITH PHARMACEUTICAL EFFECT
SE435059B (en) PROCEDURE FOR THE PREPARATION OF DIVESTUATED 1-PHENYL-2-ALKYLAMINOETHANOL COMPOUNDS WITH DIVEROCOCYLIC GROUPS
SE7805591L (en) PROCEDURE FOR THE PREPARATION OF AMINOAL CYLBENSENE DERIVATIVES WITH PHARMACEUTICAL EFFECT
NO834236L (en) PROCEDURE FOR THE PREPARATION OF 4-HALOGEN-DIHYDROPYRANE DERIVATIVES
SE429338B (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED 2-BENZYLPYRROLIDINES WITH THERAPEUTIC EFFECT
SE7701379L (en) PROCEDURE FOR PREPARATION OF BENZENDIMETHANE DERIVATIVES WITH PHARMACOLOGICAL EFFECT
SE411671B (en) PROCEDURE FOR THE PREPARATION OF TRIPEPTID DERIVATIVES WITH THERAPEUTIC EFFECT
SE7804736L (en) PROCEDURE FOR THE PREPARATION OF ISOINDOLIN DERIVATIVES WITH THERAPEUTIC EFFECT
SE434263B (en) PROCEDURE FOR THE PREPARATION OF CHLORETYL NITROSOCARBAMIDS WITH ANTITUMUM EFFECTS
SE440907B (en) PROCEDURE FOR PREPARING IMIDAZOLD DERIVATIVES WITH PHARMACEUTICAL EFFECT
SE7703721L (en) PROCEDURE FOR THE PREPARATION OF HEXAHYDROPRIMIDE COMPOUNDS WITH THERAPEUTIC EFFECT
SE7800930L (en) PROCEDURE FOR THE PREPARATION OF BENZENESULPHONAMIDE AND BENSENCARBOXAMIDE DERIVATIVES WITH THERAPEUTIC EFFECT
SE7600343L (en) PROCEDURE FOR THE PREPARATION OF FERROCENE DERIVATIVES WITH THERAPEUTIC EFFECT
SE7608538L (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED PHENYLALKYLAMINOALKYLBENSENE DERIVATIVES WITH THERAPEUTIC EFFECT
SE7608115L (en) PROCEDURE FOR THE PREPARATION OF KINOXALIN DERIVATIVES WITH THERAPEUTIC EFFECT
SE7805105L (en) PROCEDURE FOR THE PREPARATION OF PYRANOKINOLINE DERIVATIVES WITH THERAPEUTIC EFFECT
SE7708521L (en) PROCEDURE FOR THE PREPARATION OF AMINOAL CYLFURAN DERIVATIVES WITH THERAPEUTIC EFFECT
SE7712219L (en) PROCEDURE FOR THE PREPARATION OF TRANS-5A-ARYL-DEKAHYDROBENZAZPINES WITH THERAPEUTIC EFFECT
SE436496B (en) PROCEDURE FOR THE PREPARATION OF DIBENSOTIOFENDER DERIVATIVES
SE7700572L (en) PROCEDURE FOR THE PREPARATION OF TIENOPYRIDINE DERIVATIVES
SE7713839L (en) PROCEDURE FOR THE PREPARATION OF INDANDERIVATIVES WITH THERAPEUTIC EFFECT
SE7606236L (en) PROCEDURE FOR THE PREPARATION OF PIPERAZINE COMPOUNDS WITH THERAPEUTIC EFFECT
SE417712B (en) PROCEDURE FOR THE PREPARATION OF N- (6-ACYLOXYBENZOTIAZOL-2-YL) -NŸ-PHENYL URBANIMS WITH THERAPEUTIC EFFECT
SE7712217L (en) PROCEDURE FOR THE PREPARATION OF DEKAHYDROCYCLOPENT- (C) AZEPINES WITH THERAPEUTIC EFFECT

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7708521-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7708521-5

Format of ref document f/p: F